Andy and Dr. Fauci cover all the latest questions you have, including boosters, variants beyond Delta, breakthrough infections, and vaccinating the globe. Plus, what Dr. Fauci and the Biden administration are doing to prepare for the next pandemic.
Keep up with Andy on Twitter @ASlavitt and Instagram @andyslavitt.
Joining Lemonada Premium is a great way to support our show and get bonus content. Subscribe today at bit.ly/lemonadapremium.
Support the show by checking out our sponsors!
- Click this link for a list of current sponsors and discount codes for this show and all Lemonada shows: https://lemonadamedia.com/sponsors/
- Throughout the pandemic, CVS Health has been there, bringing quality, affordable health care closer to home—so it’s never out of reach for anyone.
Learn more at cvshealth.com.
Check out these resources from today’s episode:
- Read the preprint of the Israeli study of booster shots that Dr. Fauci mentions in today’s episode: https://www.medrxiv.org/content/10.1101/2021.08.27.21262679v1
- Check out the preprint of the Mayo Clinic study comparing the Moderna and Pfizer vaccines: https://www.medrxiv.org/content/10.1101/2021.08.06.21261707v3
- Learn more about what the WHO has to say about “variants of interest” like Lambda and Mu: https://www.cnbc.com/2021/09/07/mu-covid-variant-who-says-delta-remains-most-concerning.html
- Here’s more on the status of oral antiviral trials at both Pfizer and Merck: https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-starts-dosing-patients-oral-covid-19-drug-trial-2021-09-01/
- Find a COVID-19 vaccine site near you: https://www.vaccines.gov/
- Order Andy’s book, Preventable: The Inside Story of How Leadership Failures, Politics, and Selfishness Doomed the U.S. Coronavirus Response: https://us.macmillan.com/books/9781250770165
Stay up to date with us on Twitter, Facebook, and Instagram at @LemonadaMedia.
For additional resources, information, and a transcript of the episode, visit lemonadamedia.com/show/inthebubble.
See omnystudio.com/listener for privacy information.